Library
43 compounds, with half-lives, titration ladders and sources. Every dose carries a tag saying where it came from, an approved label, a clinical trial, or community practice with nothing behind it.
Your own compounds
Anything the library does not carry. Your entries work everywhere a built-in one does, protocols, logging, stock and cost, but they are never shown as researched: dose ranges are tagged as yours, there are no citations, and no curve is drawn unless you give a half-life. You can also add one straight from any compound dropdown.
None yet.
Metabolic
Growth hormone fragment marketed for fat loss. Failed its phase 2b trial.
Half-life: Not established · also hGH fragment 176-191
Long-acting amylin analogue. Investigational.
Half-life: 7.4 days · also AM833, NNC0174-0833
Fixed 1:1 combination of cagrilintide and semaglutide. Filed with the FDA, not approved.
Half-life: 7.1 days · also cagrilintide + semaglutide
The literal C-terminal fragment of growth hormone. Distinct from AOD-9604.
Half-life: Not established · also hGH 176-191
GLP-1 receptor agonist, dosed daily rather than weekly. FDA approved.
Half-life: 13 hours · also Victoza, Saxenda
GLP-1 and glucagon receptor dual agonist, an oxyntomodulin analogue. Approved in China only.
Half-life: 8 days · also IBI362, LY3305677
Triple agonist at the GIP, GLP-1 and glucagon receptors. Investigational.
Half-life: 6 days · also LY3437943, Reta
GLP-1 receptor agonist. FDA approved.
Half-life: 6.7 days · also Ozempic, Wegovy
Glucagon and GLP-1 receptor dual agonist. Investigational.
Half-life: 4.2 days · also BI 456906
GIP and GLP-1 receptor dual agonist. FDA approved.
Half-life: 5 days · also Mounjaro, Zepbound
Anabolic steroids
A long-acting veterinary androgen, originally for horses.
Half-life: Not established · also Equipoise, EQ
A non-aromatising DHT derivative, once used in breast cancer treatment.
Half-life: Not established · also Masteron, Mast P
The original oral anabolic, and still the archetype.
Half-life: 5 hours · also Dianabol, Dbol
A long-acting nandrolone ester, used clinically for anaemia and wasting.
Half-life: 6 days · also Deca-Durabolin, Deca
The short-ester nandrolone, injected every few days instead of weekly.
Half-life: Not established · also NPP, Durabolin
An oral with genuine clinical history, burns recovery and weight restoration, and the best-documented pharmacokinetics of any oral here.
Half-life: 9.4 hours · also Anavar, Oxandrin
An oral DHT derivative, historically used for hereditary angioedema.
Half-life: 9 hours · also Winstrol, Winny
Near-identical in behaviour to enanthate; the ester common in the United States.
Half-life: 4.5 days · also Test C, Depo-Testosterone
The reference long-acting testosterone ester, and the backbone of most replacement regimens.
Half-life: 4.5 days · also Test E, Delatestryl
A short ester needing frequent injection, with correspondingly little accumulation.
Half-life: 19 hours · also Test P
A very long depot given every ten to fourteen weeks rather than weekly.
Half-life: 33.9 days · also Nebido, Aveed
A cattle-growth implant compound. Never developed for human use, and no human pharmacokinetic data exists.
Half-life: Not established · also Tren A, Finaplix
The long-ester trenbolone. The same absence of human data applies.
Half-life: Not established · also Tren E
Repair & healing
Synthetic 15-amino-acid gastric peptide used for soft-tissue and gut repair.
Half-life: 25 minutes · also Body Protection Compound 157, Pentadecapeptide BPC 157
The three-amino-acid tail of alpha-MSH. Anti-inflammatory, and it works in the gut.
Half-life: Not established · also Lys-Pro-Val, alpha-MSH 11-13
BPC-157 supplied as an arginine salt. The same peptide, not a new molecule.
Half-life: 25 minutes · also PDA, BPC-157 arginate
A seven-amino-acid fragment of thymosin beta-4. Not the same molecule as thymosin beta-4 itself.
Half-life: Not established · also Ac-LKKTETQ, thymosin beta-4 fragment 17-23
Growth hormone axis
The long-acting version, which binds albumin and lasts days rather than minutes.
Half-life: 6 days · also DAC:GRF, CJC-1295 DAC
A short-acting GHRH analogue. Often paired with a ghrelin agonist.
Half-life: 30 minutes · also Modified GRF 1-29, Mod GRF 1-29
A hexapeptide ghrelin receptor agonist. Strongly appetite-stimulating.
Half-life: 2.5 hours · also SKF-110679, CIGB-500
A selective ghrelin receptor agonist, chosen for not raising cortisol or prolactin.
Half-life: 2 hours · also NNC 26-0161
Growth hormone itself, rather than something that asks your pituitary to make more of it.
Half-life: 2.6 hours · also Human growth hormone, HGH
A stabilised GHRH analogue. The only FDA-approved compound in this category.
Half-life: 24 minutes · also Egrifta, TH9507
Longevity & mitochondrial
A four-amino-acid peptide studied in Russia for telomerase activation and ageing.
Half-life: Not established · also Epithalon, Ala-Glu-Asp-Gly
A 16-amino-acid peptide encoded in mitochondrial DNA.
Half-life: Not established · also mitochondrial ORF of the twelve S rRNA type-c
Skin & cosmetic
Blends
A four-peptide repair blend, sold as 80 mg in a 5:1:1:1 ratio.
Half-life: Not established · also KLOW 80, GHK-Cu + BPC-157 + TB-500 + KPV
BPC-157 and TB-500 together, usually in equal parts.
Half-life: Not established · also BPC-157 + TB-500
Immune
The body's own 37-amino-acid antimicrobial peptide.
Half-life: Not established · also human cathelicidin, hCAP18 fragment
A 28-amino-acid thymic peptide. Approved in around 35 countries, though not the US.
Half-life: 2 hours · also thymalfasin, Zadaxin
Sexual function
Cognitive
An anxiolytic peptide developed in Russia, and the usual companion to Semax.
Half-life: Not established · also TP-7, Selanx
A heptapeptide ACTH fragment analogue, used in Russia as a nootropic and stroke drug.
Half-life: Not established · also Met-Glu-His-Phe-Pro-Gly-Pro